Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants.

Madeleine MM, Carter JJ, Johnson LG, Wipf GC, Davis C, Berg D, Nelson K, Daling JR, Schwartz SM, Galloway DA.

Cancer Med. 2014 Oct;3(5):1440-7. doi: 10.1002/cam4.280. Epub 2014 Jun 10.

2.

Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.

Li CI, Daling JR, Haugen KL, Tang MT, Porter PL, Malone KE.

Breast Cancer Res Treat. 2014 Jun;145(2):481-9. doi: 10.1007/s10549-014-2960-4. Epub 2014 Apr 20.

3.

Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.

Beaber EF, Malone KE, Tang MT, Barlow WE, Porter PL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):755-64. doi: 10.1158/1055-9965.EPI-13-0944. Epub 2014 Mar 14.

4.

Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.

Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE.

JAMA Intern Med. 2013 Sep 23;173(17):1629-37. doi: 10.1001/jamainternmed.2013.9071.

5.

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.

McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1529-37. doi: 10.1158/1055-9965.EPI-13-0414. Epub 2013 Jul 5.

6.

Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.

7.

Use of antihypertensive medications and breast cancer risk.

Saltzman BS, Weiss NS, Sieh W, Fitzpatrick AL, McTiernan A, Daling JR, Li CI.

Cancer Causes Control. 2013 Feb;24(2):365-71. doi: 10.1007/s10552-012-0122-8. Epub 2012 Dec 8.

PMID:
23224328
8.

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Breast Cancer Res Treat. 2013 Jan;137(2):579-87. doi: 10.1007/s10549-012-2365-1. Epub 2012 Dec 9.

9.

Cohort profile: the skin cancer after organ transplant study.

Madeleine MM, Johnson LG, Daling JR, Schwartz SM, Carter JJ, Berg D, Nelson K, Davis CL, Galloway DA.

Int J Epidemiol. 2013 Dec;42(6):1669-77. doi: 10.1093/ije/dys179. Epub 2012 Nov 21.

10.

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.

Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI.

Breast Cancer Res Treat. 2012 Oct;135(3):849-55. doi: 10.1007/s10549-012-2183-5. Epub 2012 Aug 19.

11.

Estrogen-related genes and their contribution to racial differences in breast cancer risk.

Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L, Spirtas R, McDonald JA, Strom BL, Burkman RT, Simon MS, Liff JM, Daling JR, Malone KE.

Cancer Causes Control. 2012 May;23(5):671-81. doi: 10.1007/s10552-012-9925-x. Epub 2012 Mar 15.

12.

Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Cancer Res. 2012 Apr 15;72(8):2028-35. doi: 10.1158/0008-5472.CAN-11-4064. Epub 2012 Feb 27.

13.

Oral contraceptive formulation and risk of breast cancer.

Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R.

Contraception. 2012 Apr;85(4):342-50. doi: 10.1016/j.contraception.2011.08.007. Epub 2011 Sep 28.

14.

Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.

Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2560-71. doi: 10.1158/1055-9965.EPI-11-0781. Epub 2011 Sep 29.

15.

Relationship between menopausal symptoms and risk of postmenopausal breast cancer.

Huang Y, Malone KE, Cushing-Haugen KL, Daling JR, Li CI.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):379-88. doi: 10.1158/1055-9965.EPI-10-0998. Epub 2011 Jan 6.

16.

Smoking during first pregnancy and breast cancer: a case-control study using Washington State registry data.

DeRoo LA, Cummings P, Daling JR, Mueller BA.

Ann Epidemiol. 2011 Jan;21(1):53-5. doi: 10.1016/j.annepidem.2010.09.004.

17.

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.

Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.

Breast Cancer Res Treat. 2011 Apr;126(3):749-61. doi: 10.1007/s10549-010-1174-7. Epub 2010 Sep 29.

18.

Relationship between diabetes and risk of second primary contralateral breast cancer.

Li CI, Daling JR, Tang MT, Malone KE.

Breast Cancer Res Treat. 2011 Jan;125(2):545-51. doi: 10.1007/s10549-010-1035-4. Epub 2010 Jul 13.

19.

Infertility treatment use in relation to selected adverse birth outcomes.

Welmerink DB, Voigt LF, Daling JR, Mueller BA.

Fertil Steril. 2010 Dec;94(7):2580-6. doi: 10.1016/j.fertnstert.2010.03.005.

PMID:
20434152
20.

Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.

Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE.

Am J Epidemiol. 2009 Nov 15;170(10):1241-9. doi: 10.1093/aje/kwp298. Epub 2009 Oct 21.

Supplemental Content

Loading ...
Support Center